The structural and compositional changes of glycosaminoglycans are closely associated with tissue type in human laryngeal cancer
- PMID: 17716802
- DOI: 10.1016/j.biochi.2007.07.006
The structural and compositional changes of glycosaminoglycans are closely associated with tissue type in human laryngeal cancer
Abstract
Hyaluronan and sulfated glycosaminoglycans, as intrinsic components of proteoglycans, are playing important roles in cancer biology. In the present study, we investigated in detail the glycosaminoglycans on both fine chemical and structural levels in laryngeal cartilaginous and non-cartilaginous tissues at different stages of laryngeal cancer. The results indicated that in cartilaginous tissues the amounts of chondroitin sulfate, keratan sulfate, dermatan sulfate and hyaluronan presented a dramatic decrease in contrast to the non-cartilaginous tissues, which showed a significant increase of these glycosaminoglycans compared to their normal counterparts. On fine chemical structure, the molar ratios of 4-sulfated to 6-sulfated and non-sulfated to sulfated disaccharides from both cartilaginous and non-cartilaginous cancerous tissues showed a significant increase. On molecular-size level, in laryngeal cancer, the chromatographic behaviour of the sulfated glycosaminoglycan chains from both tissue-types revealed their lower M(r) with a more polydisperse and heterogeneous distribution compared to the normal ones. In addition, in both tissues, a significant decrease of high molecular-size hyaluronan was observed. Of particular interest was the great increase of hyaluronan of low molecular mass in the laryngeal non-cartilaginous tissues, which ranged from 330 to 890 kDa. The kind and the extent of these alterations, which presented an intense stage-related behaviour, depended on the tissue origin and could be associated with the malignant phenotype of human laryngeal cancer.
Similar articles
-
Glycosaminoglycan in cerebrum, cerebellum and brainstem of young sheep brain with particular reference to compositional and structural variations of chondroitin-dermatan sulfate and hyaluronan.Biomed Chromatogr. 2008 Sep;22(9):931-8. doi: 10.1002/bmc.1010. Biomed Chromatogr. 2008. PMID: 18506744
-
Alterations of glycosaminoglycan disaccharide content and composition in colorectal cancer: structural and expressional studies.Oncol Rep. 2009 Aug;22(2):369-75. Oncol Rep. 2009. PMID: 19578779
-
Altered fine structures of corneal and skeletal keratan sulfate and chondroitin/dermatan sulfate in macular corneal dystrophy.J Biol Chem. 2001 Oct 26;276(43):39788-96. doi: 10.1074/jbc.M103227200. Epub 2001 Aug 20. J Biol Chem. 2001. PMID: 11514545
-
Biochemical changes of extracellular proteoglycans in squamous cell laryngeal carcinoma.Connect Tissue Res. 2008;49(3):239-43. doi: 10.1080/03008200802147662. Connect Tissue Res. 2008. PMID: 18661351 Review.
-
Sulfotransferases and sulfated oligosaccharides.Med Res Rev. 2002 Nov;22(6):637-54. doi: 10.1002/med.10020. Med Res Rev. 2002. PMID: 12369092 Review.
Cited by
-
The chondroitin/dermatan sulfate synthesizing and modifying enzymes in laryngeal cancer: expressional and epigenetic studies.Head Neck Oncol. 2010 Oct 7;2:27. doi: 10.1186/1758-3284-2-27. Head Neck Oncol. 2010. PMID: 20929582 Free PMC article.
-
Changes in composition and sulfation patterns of glycoaminoglycans in renal cell carcinoma.Glycoconj J. 2016 Feb;33(1):103-12. doi: 10.1007/s10719-015-9643-1. Epub 2015 Dec 14. Glycoconj J. 2016. PMID: 26662466
-
Hyaluronan - a functional and structural sweet spot in the tissue microenvironment.Front Immunol. 2015 May 15;6:231. doi: 10.3389/fimmu.2015.00231. eCollection 2015. Front Immunol. 2015. PMID: 26029216 Free PMC article. Review.
-
A glycosylation-related gene signature predicts prognosis, immune microenvironment infiltration, and drug sensitivity in glioma.Front Pharmacol. 2024 Jan 16;14:1259051. doi: 10.3389/fphar.2023.1259051. eCollection 2023. Front Pharmacol. 2024. PMID: 38293671 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources